Ribosome biogenesis is a downstream effector of the oncogenic U2AF1-S34F mutation

• Abdalla Akef,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Writing – original draft, Writing – review & editing

  Affiliation Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Kathy McGraw,

  Roles Methodology, Resources, Writing – review & editing

  Affiliation Department of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Steven D. Cappell,

  Roles Software, Writing – review & editing

  Affiliation Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  https://orcid.org/0000-0002-2885-7327

  ⨯
• Daniel R. Larson

  Roles Conceptualization, Formal analysis, Funding acquisition, Project administration, Resources, Software, Supervision, Writing – review & editing

  * E-mail: dan.larson@nih.gov

  Affiliation Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  https://orcid.org/0000-0001-9253-3055

  ⨯